Back to Rankings

QTTB

Q32 BioD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
QTTB vs peer average
37/100
QTTB vs. peer average (D vs. C)
Grade spread
A 1 · B 3 · C 3 · D 1 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

BTAI is the first available peer comparator.

Small-cap clinical biotech comp with binary readout and financing sensitivity; useful mainly as an event-risk and capital-markets peer, not a close mechanism match.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerBTAIBioXcel Therapeutics
QTTB
Q32 Bio
BTAI
BioXcel Therapeutics
Grade
D
F
Momentum
99
10
Value
44
41
Sentiment
0
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs BTAI

QTTB / BTAI
Grade Position
Below peers
QTTB vs. peer average (D vs. C)
37/100
Momentum
99
QTTB
Value
44
QTTB
Sentiment
0
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs QTTB
1
BTAI
BTAI
F
20/100
+1
2
INMB
INMB
F
20/100
+1
3
IBIO
IBIO
A
100/100
-3
4
PRTA
Prothena Corp Plc Common
C
60/100
-1
5
CABA
Cabaletta Bio Inc Common
D
40/100
Even
BTAI is the first peer returned for this comparison set.